Wai Kwan Chung

Title: Wai Kwan Chung: Innovator in Immunogenic Compositions

Introduction

Wai Kwan Chung is a notable inventor based in Hagerstown, MD (US). He has made significant contributions to the field of immunology, particularly in the development of vaccines. His work focuses on enhancing immune responses through innovative compositions.

Latest Patents

Wai Kwan Chung holds a patent titled "Immunogenicity of a CpG-adjuvanted recombinant plague vaccine." This patent relates to immunogenic compositions that include at least one antigen, an aluminum salt adjuvant, and an oligonucleotide featuring an unmethylated cytidine-phospho-guanosine (CpG) motif. These compositions are designed to stimulate an immune response in subjects who require it. The patent also discusses kits and methods that utilize these immunogenic compositions.

Career Highlights

Throughout his career, Wai Kwan Chung has worked with prominent organizations, including Dynavax Technologies Corporation and the U.S. Government as represented by the Secretary of the Army. His experience in these institutions has allowed him to contribute to significant advancements in vaccine technology.

Collaborations

Wai Kwan Chung has collaborated with esteemed colleagues such as Robert S. Janssen and David Novack. These partnerships have further enriched his research and development efforts in the field of immunology.

Conclusion

Wai Kwan Chung's innovative work in immunogenic compositions highlights his commitment to advancing vaccine technology. His contributions are vital in the ongoing efforts to enhance immune responses and combat infectious diseases.